Anti-CD28/anti-HMV-MAA bispecific antibody (Eberhard-Karls-Universitaet Tuebingen)
- Generic Name
- Anti-CD28/anti-HMV-MAA bispecific antibody (Eberhard-Karls-Universitaet Tuebingen)
Local Treatment of Metastatic Melanoma With Autologous Lymphocytes and the Bispecific Antibody rM28
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2013-01-16
- Lead Sponsor
- University Hospital Tuebingen
- Target Recruit Count
- 1
- Registration Number
- NCT00204594
- Locations
- 🇩🇪
University of Tuebingen, Department of dermatology, Tuebingen, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath